Vizionfocus Inc. (4771) fair value: what the stock is really worth
As of Sep 24, 2026: fair value of Vizionfocus Inc. TWD 279, price TWD 212, upside +31.7%, quality 43 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Vizionfocus Inc. for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
Vizionfocus Inc. engages in the manufacturing of medical equipment in Japan, China, Southeast Asia and the United States. It also manufactures mechanical equipment, optical instruments, and precision instruments; trades internationally; and provides other consulting services.
Show more
Vizionfocus Inc. engages in the manufacturing of medical equipment in Japan, China, Southeast Asia and the United States. It also manufactures mechanical equipment, optical instruments, and precision instruments; trades internationally; and provides other consulting services. In addition, the company engages in the research and development, design, OEM, development, and sale of contact lenses, as well as customized services. Vizionfocus Inc. was founded in 2012 and is headquartered in Miaoli, Taiwan.
Stock analysis
Vizionfocus Inc. (4771) currently trades at 212.00 TWD, while our model-based Fair Value estimate is 279.11 TWD, implying the stock looks roughly 24.0% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of 444.09 TWD per share, and 8 of the 17 models we run sit above the 212.00 TWD price.
Bear case: the DCF Models group reads lowest at 36.79 TWD, and 9 of the 17 models stay below the price. Evidence for this calculation is medium.
Scenario range: 206.79 TWD (bear) to 351.43 TWD (bull), the price of 212.00 TWD sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 43/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Vizionfocus Inc. reported revenue of 3.5B TWD in FY2025 versus 1.4B TWD in FY2021, a compound +25.2%/yr. Reported net income was 808M TWD in FY2025, compounding +36.3%/yr from FY2021.
Key figures
Market cap 13.5B TWD (≈ $423M) · P/E ratio 16.9 · P/S ratio 3.90 · EPS (TTM) 12.58 TWD · Dividend yield 3.3% · Net margin 23.2% · Return on equity 19.2% · Return on assets (EBIT) 15.0%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (low confidence).
What moves the price
The share trades about 3% below its 52-week high and 25% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −12% fair-value upside, at 32%, 4771 screens cheaper than that median.
Fair Value models
Bear 206.79 TWDFair Value 279.11 TWDBull 351.43 TWD
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (4.10 TWD per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+16.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+23.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+32.5%
Start year 2020 (pandemic)
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+34.7%
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in TWD ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in TWD: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+37.4%
Earnings growth per share plus dividend.
Earnings per share, growth per year+34.1%
Dividend (yield on the price)3.3%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.18% → 29%
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 203 stocks
Beats the industry median on 9/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score43 · Bottom 25%
Fair Value upside+32% · Top 25%
Profitability
Return on equity (TTM)19% · Top 25%
Return on assets10% · Top 25%
Net margin (TTM)21% · Top 25%
Operating margin (TTM)29% · Top 25%
Growth and dividend
Revenue growth27% · Top 25%
Dividend yield (TTM)3.3% · Above median
Balance sheet
Debt / equity0.28× · Above median
Valuation Multiplesvs Medical Instruments & Supplies median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Vizionfocus Inc. Fair Value". https://www.fairvalue-calculator.com/stock/4771
Frequently asked questions
Is Vizionfocus Inc. (4771) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 279.11 TWD versus a price of 212.00 TWD, about +32% upside (undervalued).
What is the fair value of 4771?
Our model-based fair value for Vizionfocus Inc. is 279.11 TWD (as of Sep 24, 2026), built from audited fundamentals. The current price: 212.00 TWD.
What is the quality score of 4771?
Vizionfocus Inc. has a Quality Score of 43/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Vizionfocus Inc. (4771)?
Our model-based price target is the fair value of 279.11 TWD (as of Sep 24, 2026) from 17 valuation models. Cautious scenario 206.79 TWD, optimistic scenario 351.43 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the Vizionfocus Inc. stock forecast for 2026?
Our models put fair value at 279.11 TWD, about +32% upside versus a price of 212.00 TWD (undervalued). Cautious scenario 206.79 TWD, optimistic scenario 351.43 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of Vizionfocus Inc. (4771)?
Vizionfocus Inc. reported trailing-twelve-month revenue of about 3.7B TWD (latest available figure, as of Sep 24, 2026).
Does Vizionfocus Inc. pay a dividend?
Vizionfocus Inc. currently shows a dividend yield of about 3.30% relative to its recent price (as of Sep 24, 2026).
What is the intrinsic value of Vizionfocus Inc. (4771)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Vizionfocus Inc. it is 279.11 TWD per share (as of Sep 24, 2026), against a price of 212.00 TWD. It is the blended result of 17 valuation models (cash flow, earnings, asset, dividend).
Is Vizionfocus Inc. stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 4771 trades below its calculated fair value: price 212.00 TWD, fair value 279.11 TWD, a gap of about +32% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 4771?
No. The price is what the market pays today (212.00 TWD); the fair value is what the company's own numbers justify (279.11 TWD). For Vizionfocus Inc. the two are 67.11 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is Vizionfocus Inc. worth?
The market values Vizionfocus Inc. at about 13.5B TWD (market capitalisation, as of Sep 24, 2026). Per share that is 212.00 TWD; our models calculate a fair value of 279.11 TWD per share.
What do the bullish and bearish scenarios say about 4771?
Our models span a range for Vizionfocus Inc.: cautious scenario 206.79 TWD, base 279.11 TWD, optimistic 351.43 TWD per share (as of Sep 24, 2026, price 212.00 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 4771?
Vizionfocus Inc. trades at a price-to-earnings ratio of 16.9 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 279.11 TWD is built from several models across several years. Other multiples: P/B 3.4, P/S 3.6, EV/EBITDA 9.5.
How solid is the balance sheet of Vizionfocus Inc. (4771)?
Balance-sheet figures for Vizionfocus Inc. (as of Sep 24, 2026): return on equity 19.2%, debt of 0.28 per unit of equity. They feed the Quality Score of 43/100, which measures business quality independently of the share price.
How far is 4771 from its 52-week high?
Vizionfocus Inc. trades at 212.00 TWD, about 3% below its 52-week high of 219.00 TWD and 25% above the low of 170.00 TWD (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of 279.11 TWD is for.
Which stocks are comparable to Vizionfocus Inc.?
From the same area (Healthcare) we also value Intuitive Surgical, Inc, EssilorLuxottica Société anonyme, Medline Inc, Becton, Dickinson and Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Vizionfocus Inc. stock attractive at the current price?
The data as of Sep 24, 2026: price 212.00 TWD, calculated fair value 279.11 TWD (+32%), Quality Score 43/100, from 17 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 4771 calculated?
We run Vizionfocus Inc. through 17 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 279.11 TWD, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.2 % above its aggregate fair value. Vizionfocus Inc. currently trades 32 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Vizionfocus Inc. (4771)?
The closing price on Sep 24, 2026 was 212.00 TWD. Our model-based fair value is 279.11 TWD, about +32% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Vizionfocus Inc. right now?
The large discount to fair value meets weak quality (43/100). That raises the risk this is a value trap rather than a bargain. The price sits in the lower half of our model range, the side with the larger margin of safety. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.
Key figures of Vizionfocus Inc.
How large is the market capitalisation of Vizionfocus Inc. (4771)?
The market capitalisation of Vizionfocus Inc. is 13.5B TWD (≈ $423M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Vizionfocus Inc. (4771)?
The price-to-sales ratio of Vizionfocus Inc. is 3.90 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Vizionfocus Inc. (4771)?
Earnings per share at Vizionfocus Inc. are 12.58 TWD (price ÷ EPS = P/E 16.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Vizionfocus Inc. (4771)?
The dividend yield of Vizionfocus Inc. is 3.3% (payout 55.6%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Vizionfocus Inc. (4771)?
The net margin of Vizionfocus Inc. is 23.2% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Vizionfocus Inc. (4771)?
The return on equity (ROE) of Vizionfocus Inc. is 19.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Vizionfocus Inc. (4771)?
On an EBIT basis the return on assets of Vizionfocus Inc. is 15.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Vizionfocus Inc. (4771)?
The operating margin of Vizionfocus Inc. is 28.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Vizionfocus Inc. (4771)?
Revenue at Vizionfocus Inc. is growing +27.2% versus a year earlier (3y avg +23.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Vizionfocus Inc. (4771)?
Earnings per share at Vizionfocus Inc. are growing +11.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Vizionfocus Inc. (4771) generate?
The free cash flow of Vizionfocus Inc. is −78.2M TWD (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Vizionfocus Inc. (4771) carry?
The net debt of Vizionfocus Inc. is 597M TWD (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Vizionfocus Inc. in the live analysis
One click puts Vizionfocus Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
